HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Clinical trials for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN explained in plain language.
Never miss a new study
Get alerted when new HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN trials appear
Sign up with your email to follow new studies for HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug could save babies from deadly blood disorder in the womb
Disease control Recruiting nowThis study tests a medicine called nipocalimab in pregnant people whose babies are at high risk for a severe blood condition (HDFN) that can cause dangerous anemia. The goal is to see if the drug can prevent the need for blood transfusions in the womb and reduce the risk of death…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New global registry aims to understand risks of fetal anemia from blood type mismatch
Knowledge-focused Recruiting nowThis study is a global registry that will follow about 175 pregnant people who are at risk for hemolytic disease of the fetus and newborn (HDFN), a condition where the mother's and baby's blood types don't match, causing the baby's red blood cells to break down too fast. Research…
Matched conditions: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
Sponsor: Janssen Research & Development, LLC • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC